Key statistics
On Tuesday, Biontech SE (B1NT34:SAO) closed at 37.36, 39.40% above the 52 week low of 26.80 set on Jul 04, 2024.
52-week range
Open | 36.70 |
---|---|
High | 37.36 |
Low | 36.70 |
Bid | 35.80 |
Offer | 37.36 |
Previous close | 37.36 |
Average volume | 147.30 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 01 2025 21:05 BST.
More ▼
- EQS-News: Mallia Innovations: Mallia Appoints Jens Holstein, Dr. Alexandra Ogilvie, and Dr. Ulrich Dauer to its Advisory Board
- EQS-News: MIG Capital Announces €50 Million in Series A Funding for Look Up
- BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
- BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an
- EQS-News: Mallia sets strategic course for future and completes €5.5 million financing
- BioNTech und Bristol Myers Squibb geben globale strategische Partnerschaft zur gemeinsamen Entwicklung und Kommerzialisierung des bispezifischen Antikörperkandidaten BNT327 in einer Vielzahl solider Tumorarten bekannt
- BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
- BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
- BioNTech präsentiert auf der ASCO-Jahrestagung 2025 Fortschritte aus der diversifizierten Onkologie-Pipeline
- EQS-News: CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
More ▼